{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:02:14Z","timestamp":1792335734911,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.anai.2018.07.027","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T02:54:30Z","timestamp":1532660070000},"page":"545-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of anaphylaxis and allergies in patients with long QT syndrome"],"prefix":"10.1016","volume":"121","author":[{"given":"Tatjana","family":"Welzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-4212","authenticated-orcid":false,"given":"Victoria C.","family":"Ziesenitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Donner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes N.","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.07.027_bib0001","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40272-014-0090-4","article-title":"Congenital long QT syndromes: prevalence, pathophysiology and management","volume":"16","author":"Barsheshet","year":"2014","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.anai.2018.07.027_bib0002","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.anai.2018.07.027_bib0003","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","article-title":"QTc behavior during exercise and genetic testing for the long-QT syndrome","volume":"124","author":"Schwartz","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.anai.2018.07.027_bib0004","doi-asserted-by":"crossref","unstructured":"Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761\u20131767.","DOI":"10.1161\/CIRCULATIONAHA.109.863209"},{"key":"10.1016\/j.anai.2018.07.027_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0006","doi-asserted-by":"crossref","unstructured":"Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008; 51:2291\u20132300.","DOI":"10.1016\/j.jacc.2008.02.068"},{"key":"10.1016\/j.anai.2018.07.027_bib0007","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00431-008-0896-6","article-title":"QT interval prolongation and risk for cardiac events in genotyped LQTS-index children","volume":"168","author":"Wedekind","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.anai.2018.07.027_bib0008","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/pace.13296","article-title":"Acquired long QT syndrome and torsade de pointes","volume":"41","author":"El-Sherif","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2125.2002.01627.x","article-title":"The significance of QT interval in drug development","volume":"54","author":"Shah","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.anai.2018.07.027_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3344\/kjp.2018.31.1.3","article-title":"Pain medication and long QT syndrome","volume":"31","author":"Klivinyi","year":"2018","journal-title":"Korean J Pain"},{"key":"10.1016\/j.anai.2018.07.027_bib0011","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.anai.2016.08.004","article-title":"Long QT syndrome and life-threatening anaphylaxis: is epinephrine safe?","volume":"117","author":"White","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0012","first-page":"100","article-title":"Management of asthma in children with long QT syndrome","volume":"13","author":"Collins","year":"2012","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.anai.2018.07.027_bib0013","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.amjcard.2008.05.029","article-title":"Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists","volume":"102","author":"Thottathil","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00002018-199512050-00002","article-title":"Anaphylactoid and anaphylactic reactions: hazards of \u03b2-blockers","volume":"12","author":"Lang","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.anai.2018.07.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185680","article-title":"Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: a meta-analysis","volume":"12","author":"Ahn","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.anai.2018.07.027_bib0016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0017","doi-asserted-by":"crossref","first-page":"542","DOI":"10.47102\/annals-acadmedsg.V45N12p542","article-title":"Anaphylaxis in children: experience of 485 episodes in 1,272,482 patient attendances at a tertiary paediatric emergency department from 2007 to 2014","volume":"45","author":"Ganapathy","year":"2016","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.anai.2018.07.027_bib0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s40629-014-0009-1","volume":"23","author":"Ring","year":"2014","journal-title":"Allergo J Intl"},{"key":"10.1016\/j.anai.2018.07.027_bib0019","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1542-474X.2011.00426.x","article-title":"Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype","volume":"16","author":"Hekkala","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.hrtlng.2014.07.004","article-title":"Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier","volume":"43","author":"Tan","year":"2014","journal-title":"Heart Lung"},{"key":"10.1016\/j.anai.2018.07.027_bib0021","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jelectrocard.2006.05.013","article-title":"Epinephrine QT stress testing in congenital long QT syndrome","volume":"39","author":"Vyas","year":"2006","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0022","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00246-009-9603-2","article-title":"The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome","volume":"31","author":"Clur","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0023","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4070\/kcj.2009.39.9.386","article-title":"Epinephrine-induced polymorphic ventricular tachycardia in a patient with congenital long QT syndrome","volume":"39","author":"Kim","year":"2009","journal-title":"Korean Circ J"},{"key":"10.1016\/j.anai.2018.07.027_bib0024","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.hrthm.2015.08.021","article-title":"Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction","volume":"13","author":"Chen","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.anai.2018.07.027_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0091-6749(98)70190-3","article-title":"Epinephrine absorption in children with a history of anaphylaxis","volume":"101","author":"Simons","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/emj.2005.023507","article-title":"Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers","volume":"22","author":"Thomas","year":"2005","journal-title":"Emerg J Med"},{"key":"10.1016\/j.anai.2018.07.027_bib0027","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.joms.2009.06.008","article-title":"Management protocol for anaphylaxis","volume":"68","author":"Sharma","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.anai.2018.07.027_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/ACI.0000000000000080","article-title":"Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails","volume":"14","author":"Kemp","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13601-017-0182-7","article-title":"How to manage anaphylaxis in primary care","volume":"7","author":"Alvarez-Perea","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2018.07.027_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/10.suppl_B.11","article-title":"Coexistence and localization of \u03b21- and \u03b22-adrenoceptors in the human heart","volume":"10","author":"Summers","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.anai.2018.07.027_bib0031","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1081-1206(10)60431-0","article-title":"Hypotension from epinephrine in a food-allergic patient with long QT syndrome","volume":"100","author":"Permaul","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0032","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-662-44605-8_15","article-title":"Antihistamines and itch","volume":"226","author":"Thurmond","year":"2015","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1016\/j.anai.2018.07.027_bib0033","first-page":"837","article-title":"First-aid treatment of anaphylaxis to food: focus on epinephrine","volume":"113","author":"Simons","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-199921001-00003","article-title":"Blockade of cardiac potassium and other channels by antihistamines","volume":"21(suppl 1)","author":"Delpon","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.anai.2018.07.027_bib0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00106-012-2588-9","article-title":"Management of anaphylaxis, part 2: treatment and emergency equipment [in German]","volume":"60","author":"Klimek","year":"2012","journal-title":"HNO"},{"key":"10.1016\/j.anai.2018.07.027_bib0036","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2005.09.017","article-title":"Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel","volume":"40","author":"Ridley","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.anai.2018.07.027_bib0037","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.70.5.469","article-title":"Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion","volume":"70","author":"Broadhurst","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.anai.2018.07.027_bib0038","doi-asserted-by":"crossref","unstructured":"Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 1996 Apr 29;385:77-80.","DOI":"10.1016\/0014-5793(96)00355-9"},{"key":"10.1016\/j.anai.2018.07.027_bib0039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-199957010-00004","article-title":"Second-generation antihistamines: a comparative review","volume":"57","author":"Slater","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.anai.2018.07.027_bib0040","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.hrthm.2005.08.007","article-title":"Drug-induced torsades de pointes: the evolving role of pharmacogenetics","volume":"2","author":"Fitzgerald","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.anai.2018.07.027_bib0041","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.anai.2018.07.027_bib0042","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002018-199921001-00009","article-title":"Cardiac effects of ebastine and other antihistamines in humans","volume":"21","author":"Moss","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.anai.2018.07.027_bib0043","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1099-081X(199903)20:2<101::AID-BDD160>3.0.CO;2-L","article-title":"Pharmacokinetic-pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats","volume":"20","author":"Ohtani","year":"1999","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.anai.2018.07.027_bib0044","first-page":"389","article-title":"Potential cardiac toxicity of H1-antihistamines","volume":"17","author":"Yap","year":"2002","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0045","first-page":"26","article-title":"Cetirizine and loratadine: minimal risk of QT prolongation","volume":"19","year":"2010","journal-title":"Prescrire Int"},{"key":"10.1016\/j.anai.2018.07.027_bib0046","doi-asserted-by":"crossref","unstructured":"Delp\u00f3n E, Valenzuela C, Tamargo J. Blockade of cardiac potassium and other channels by antihistamines. Drug Saf. 1999;21(Suppl 1):11-18, discussion 81-87.","DOI":"10.2165\/00002018-199921001-00003"},{"key":"10.1016\/j.anai.2018.07.027_bib0047","first-page":"13","article-title":"Effect of H1 antihistamines upon the cardiovascular system","volume":"16","author":"Davila","year":"2006","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0048","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0149-2918(00)88286-7","article-title":"Second-generation antihistamines: the risk of ventricular arrhythmias","volume":"21","author":"DuBuske","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2018.07.027_bib0049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003088-200241001-00005","article-title":"Lack of clinically relevant interaction between desloratadine and erythromycin","volume":"41","author":"Banfield","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.anai.2018.07.027_bib0050","first-page":"347","article-title":"Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: focus on the choice of anti-H1 drugs","volume":"38","author":"Moneret-Vautrin","year":"2006","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.027_bib0051","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1365-2133.2000.03576.x","article-title":"Fexofenadine-induced QT prolongation: a myth or fact?","volume":"142","author":"Dhar","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2018.07.027_bib0052","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-2222.1999.0290s3212.x","article-title":"Cardiovascular safety of fexofenadine HCl","volume":"29","author":"Pratt","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2018.07.027_bib0053","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00228-007-0366-5","article-title":"Levocetirizine does not prolong the QT\/QTc interval in healthy subjects: results from a thorough QT study","volume":"63","author":"Hulhoven","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.anai.2018.07.027_bib0054","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.resuscitation.2015.07.028","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015, section 6: paediatric life support","volume":"95","author":"Maconochie","year":"2015","journal-title":"Resuscitation"},{"key":"10.1016\/j.anai.2018.07.027_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.resuscitation.2015.07.016","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015, section 3: adult advanced life support","volume":"95","author":"Soar","year":"2015","journal-title":"Resuscitation"},{"key":"10.1016\/j.anai.2018.07.027_bib0056","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.resuscitation.2015.07.017","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015, section 4: cardiac arrest in special circumstances","volume":"95","author":"Truhlar","year":"2015","journal-title":"Resuscitation"},{"key":"10.1016\/j.anai.2018.07.027_bib0057","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.resuscitation.2010.08.015","volume":"81","author":"Soar","year":"2010","journal-title":"Resuscitation"},{"key":"10.1016\/j.anai.2018.07.027_bib0058","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1542\/peds.2011-0539","article-title":"NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population","volume":"128","author":"Burks","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2018.07.027_bib0059","unstructured":"Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online. Hudson, Ohio: Lexi-Comp, Inc; 2013. https:\/\/www.uptodate.com. Accessed September 20, 2018."}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618306136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618306136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:21:06Z","timestamp":1761052866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618306136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1081120618306136"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.027","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of anaphylaxis and allergies in patients with long QT syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}